Covered recipient · General Payments record
MARK L MOSTER
Allopathic & Osteopathic Physicians Ophthalmology Neuro-ophthalmology
General Payments · PY2018–2024
$70,433.89
- Reported across 258 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,760.00 | 1 |
| Food and Beverage | $859.64 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $3,040.04 | 3 |
| Bausch & Lomb Americas Inc. | $317.95 | 3 |
| ABBVIE INC. | $124.48 | 1 |
| Sight Sciences, Inc. | $62.94 | 1 |
| Thea Pharma Inc. | $42.41 | 1 |
| W. L. Gore & Associates, Inc. | $31.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.48 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073309 | CMS |
| Amgen Inc. | $133.10 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656752 | CMS |
| Amgen Inc. | $2,760.00 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111656754 | CMS |
| Amgen Inc. | $146.94 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656756 | CMS |
| Bausch & Lomb Americas Inc. | $128.67 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140403646 | CMS |
| Bausch & Lomb Americas Inc. | $97.24 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140403644 | CMS |
| Bausch & Lomb Americas Inc. | $92.04 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140403648 | CMS |
| Sight Sciences, Inc. | $62.94 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151928563 | CMS |
| Thea Pharma Inc. | $42.41 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543345 | CMS |
| W. L. Gore & Associates, Inc. | $31.82 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148069685 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.